Background - Pulmonary vein isolation (PVI) is an effective treatment strategy for patients with atrial fibrillation (AF), but many experience AF recurrence and require repeat ablation procedures. The goal of this study was to develop and evaluate a methodology which combines machine learning (ML) and personalized computational modeling to predict, prior to PVI, which patients are most likely to experience AF recurrence after PVI. Methods - This single-center retrospective proof-of-concept study included 32 patients with documented paroxysmal AF who underwent PVI and had pre-procedural late gadolinium enhanced magnetic resonance imaging (LGE-MRI). For each patient, a personalized computational model of the left atrium simulated AF induction via rapid pacing. Features were derived from pre-PVI LGE-MRI images and from results of simulations (SimAF). The most predictive features were used as input to a quadratic discriminant analysis ML classifier, which was trained, optimized, and evaluated with 10-fold nested cross validation to predict the probability of AF recurrence post-PVI. Results - In our cohort, the ML classifier predicted probability of AF recurrence with an average validation sensitivity and specificity of 82% and 89%, respectively, and a validation AUC of 0.82. Dissecting the relative contributions of SimAF and raw images to the predictive capability of the ML classifier, we found that when only features from SimAF were used to train the ML classifier, its performance remained similar (validation AUC=0.81). However, when only features extracted from raw images were used for training, the validation AUC significantly decreased (0.47). Conclusions - ML and personalized computational modeling can be used together to accurately predict, using only pre-PVI LGE-MRI scans as input, whether a patient is likely to experience AF recurrence following PVI, even when the patient cohort is small.

The main purpose of the study was to develop a high accuracy system able to diagnose skin lesions using deep learning–based methods. We propose a new decision system based on multiple classifiers like neural networks and feature–based methods. Each classifier (method) gives the final decision system a certain weight, depending on the calculated accuracy, helping the system make a better decision. First, we created a neural network (NN) that can differentiate melanoma from benign nevus. The NN architecture is analyzed by evaluating it during the training process. Some biostatistic parameters, such as accuracy, specificity, sensitivity, and Dice coefficient are calculated. Then, we developed three other methods based on convolutional neural networks (CNNs). The CNNs were pre-trained using large ImageNet and Places365 databases. GoogleNet, ResNet-101, and NasNet-Large, were used in the enumeration order. CNN architectures were fine-tuned in order to distinguish the different types of skin lesions using transfer learning. The accuracies of the classifications were determined. The last proposed method uses the classical method of image object detection, more precisely, the one in which some features are extracted from the images, followed by the classification step. In this case, the classification was done by using a support vector machine. Just as in the first method, the sensitivity, specificity, Dice similarity coefficient and accuracy are determined. A comparison of the obtained results from all the methods is then done. As mentioned above, the novelty of this paper is the integration of these methods in a global fusion-based decision system that uses the results obtained by each individual method to establish the fusion weights. The results obtained by carrying out the experiments on two different free databases shows that the proposed system offers higher accuracy results.

Machine learning (ML), a branch of artificial intelligence, where machines learn from big data, is at the crest of a technological wave of change sweeping society. Cardiovascular medicine is at the forefront of many ML applications, and there is a significant effort to bring them into mainstream clinical practice. In the field of cardiac electrophysiology, ML applications have also seen a rapid growth and popularity, particularly the use of ML in the automatic interpretation of ECGs, which has been extensively covered in the literature. Much lesser known are the other aspects of ML application in cardiac electrophysiology and arrhythmias, such as those in basic science research on arrhythmia mechanisms, both experimental and computational; in the development of better techniques for mapping of cardiac electrical function; and in translational research related to arrhythmia management. In the current review, we examine comprehensively such ML applications as they match the scope of this journal. The current review is organized in 3 parts. The first provides an overview of general ML principles and methodologies that will afford readers of the necessary information on the subject, serving as the foundation for inviting further ML applications in arrhythmia research. The basic information we provide can serve as a guide on how one might design and conduct an ML study. The second part is a review of arrhythmia and electrophysiology studies in which ML has been utilized, highlighting the broad potential of ML approaches. For each subject, we outline comprehensively the general topics, while reviewing some of the research advances utilizing ML under the subject. Finally, we discuss the main challenges and the perspectives for ML-driven cardiac electrophysiology and arrhythmia research.

Sudden cardiac death from arrhythmia is a major cause of mortality worldwide. In this study, we developed a novel deep learning (DL) approach that blends neural networks and survival analysis to predict patient-specific survival curves from contrast-enhanced cardiac magnetic resonance images and clinical covariates for patients with ischemic heart disease. The DL-predicted survival curves offer accurate predictions at times up to 10 years and allow for estimation of uncertainty in predictions. The performance of this learning architecture was evaluated on multi-center internal validation data and tested on an independent test set, achieving concordance indexes of 0.83 and 0.74 and 10-year integrated Brier scores of 0.12 and 0.14. We demonstrate that our DL approach, with only raw cardiac images as input, outperforms standard survival models constructed using clinical covariates. This technology has the potential to transform clinical decision-making by offering accurate and generalizable predictions of patient-specific survival probabilities of arrhythmic death over time.